Welcome to the upgraded MacSphere! We're putting the finishing touches on it; if you notice anything amiss, email macsphere@mcmaster.ca

Cost-effectiveness of enoxaparin versus warfarin for prevention of deep vein thrombosis following total hip replacement

Simple item page
dc.contributor.authorO'Brien, Bernie J.en_US
dc.contributor.authorAnderson, David.en_US
dc.contributor.authorGoeree, Ron.en_US
dc.contributor.authorCentre for Health Economics and Policy Analysisen_US
dc.date.accessioned2015-04-14T14:41:58Z
dc.date.available2015-04-14T14:41:58Z
dc.date.issued1993en_US
dc.descriptionBernie J. O'Brien, David Anderson, Ron Goeree. --en_US
dc.descriptionBibliography: leaves 19-22.en_US
dc.format.extent23 leaves.en_US
dc.identifier.urihttp://hdl.handle.net/11375/17017
dc.publisherMcMaster Universityen_US
dc.relation.ispartofseriesCHEPA working paper series no. 93-6en_US
dc.subjectCost-Benefit Analysisen_US
dc.subjectHeparin, Low-Molecular Weighten_US
dc.subjecttherapeutic useen_US
dc.subjectHeparin, Low-Molecular Weighten_US
dc.subjecteconomicsen_US
dc.subjectHip Prosthesisen_US
dc.subjectcomplicationsen_US
dc.subjectThrombophlebitisen_US
dc.subjectprevention & controlen_US
dc.subjectWarfarinen_US
dc.subjecttherapeutic useen_US
dc.subjectWarfarinen_US
dc.subjecteconomicsen_US
dc.subjectEconomics, Medicalen_US
dc.titleCost-effectiveness of enoxaparin versus warfarin for prevention of deep vein thrombosis following total hip replacementen_US
dc.title.alternativeEnoxaparin versus warfarin for prevention of deep vein thrombosis following total hip replacementen_US
dc.typetexten_US

Files

Collections

CHEPA Working Paper Series